Synergen INDs
Executive Summary
Boulder, Colo.-based biotech firm's annual report for 1987 notes plan to put angiogenesis factor in clinical trials for wound healing in second half of 1988. Also approaching the clinic is the firm's elastase inhibitor, a collaborative project between Synergen and Ciba-Geigy.